These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 2551499)
1. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene. Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499 [TBL] [Abstract][Full Text] [Related]
2. SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis. Butel JS; Sepulveda AR; Finegold MJ; Woo SL Intervirology; 1990; 31(2-4):85-100. PubMed ID: 2142679 [TBL] [Abstract][Full Text] [Related]
3. Multistep hepatocarcinogenesis in transgenic mice harboring SV40 T-antigen gene. Kitagawa T; Hino O; Lee GH; Li H; Liu J; Nomura K; Ohtake K; Furuta Y; Aizawa S Princess Takamatsu Symp; 1991; 22():349-60. PubMed ID: 1668891 [TBL] [Abstract][Full Text] [Related]
4. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas. Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690 [TBL] [Abstract][Full Text] [Related]
5. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats. Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347 [TBL] [Abstract][Full Text] [Related]
6. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981 [TBL] [Abstract][Full Text] [Related]
7. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice. Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418 [TBL] [Abstract][Full Text] [Related]
8. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Lednicky JA; Garcea RL; Bergsagel DJ; Butel JS Virology; 1995 Oct; 212(2):710-7. PubMed ID: 7571441 [TBL] [Abstract][Full Text] [Related]
9. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
10. Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice. Bennoun M; Rissel M; Engelhardt N; Guillouzo A; Briand P; Weber-Benarous A Am J Pathol; 1993 Nov; 143(5):1326-36. PubMed ID: 7694468 [TBL] [Abstract][Full Text] [Related]
11. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences. March KL; Sandusky G; Fan L Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686 [TBL] [Abstract][Full Text] [Related]
12. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. Pousset D; Piller V; Bureaud N; Monsigny M; Piller F Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085 [TBL] [Abstract][Full Text] [Related]
13. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096 [TBL] [Abstract][Full Text] [Related]
14. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. Shibata MA; Ward JM; Devor DE; Liu ML; Green JE Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741 [TBL] [Abstract][Full Text] [Related]
16. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer progression, metastasis, and gene expression in transgenic mice. Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192 [TBL] [Abstract][Full Text] [Related]
18. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen. Marcus DM; Lasudry JG; Carpenter JL; Windle J; Howes KA; al-Ubaidi MR; Baehr W; Overbeek PA; Font RL; Albert DM Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):392-6. PubMed ID: 8603844 [TBL] [Abstract][Full Text] [Related]
19. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304 [TBL] [Abstract][Full Text] [Related]
20. Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells. O'Neill FJ; Carney H; Hu Y Dev Biol Stand; 1998; 94():191-205. PubMed ID: 9776240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]